A citation-based method for searching scientific literature

Antonio Pérez, Analia Ramos, Gemma Carreras. Am J Ther 2020
Times Cited: 8







List of co-cited articles
30 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline.
Guillermo E Umpierrez, Richard Hellman, Mary T Korytkowski, Mikhail Kosiborod, Gregory A Maynard, Victor M Montori, Jane J Seley, Greet Van den Berghe. J Clin Endocrinol Metab 2012
587
50

Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial).
Guillermo E Umpierrez, Dawn Smiley, Ariel Zisman, Luz M Prieto, Andres Palacio, Miguel Ceron, Alvaro Puig, Roberto Mejia. Diabetes Care 2007
395
50

COVID-19 and diabetes: Can DPP4 inhibition play a role?
Gianluca Iacobellis. Diabetes Res Clin Pract 2020
146
37

Comparison of Basal-Bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes.
Virginia Bellido, Lorena Suarez, Maria Galiana Rodriguez, Cecilia Sanchez, Marta Dieguez, Maria Riestra, Florentino Casal, Elias Delgado, Edelmiro Menendez, Guillermo E Umpierrez. Diabetes Care 2015
50
37

Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery).
Guillermo E Umpierrez, Dawn Smiley, Sol Jacobs, Limin Peng, Angel Temponi, Patrick Mulligan, Denise Umpierrez, Christopher Newton, Darin Olson, Monica Rizzo. Diabetes Care 2011
371
37

Randomized study comparing a Basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial.
Guillermo E Umpierrez, Dawn Smiley, Kathie Hermayer, Amna Khan, Darin E Olson, Christopher Newton, Sol Jacobs, Monica Rizzo, Limin Peng, David Reyes,[...]. Diabetes Care 2013
112
37

American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control.
Etie S Moghissi, Mary T Korytkowski, Monica DiNardo, Daniel Einhorn, Richard Hellman, Irl B Hirsch, Silvio E Inzucchi, Faramarz Ismail-Beigi, M Sue Kirkman, Guillermo E Umpierrez. Diabetes Care 2009
737
37


Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes.
Lihua Zhu, Zhi-Gang She, Xu Cheng, Juan-Juan Qin, Xiao-Jing Zhang, Jingjing Cai, Fang Lei, Haitao Wang, Jing Xie, Wenxin Wang,[...]. Cell Metab 2020
554
37

Prevalence and impact of diabetes among people infected with SARS-CoV-2.
G P Fadini, M L Morieri, E Longato, A Avogaro. J Endocrinol Invest 2020
176
25

Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States.
Bruce Bode, Valerie Garrett, Jordan Messler, Raymie McFarland, Jennifer Crowe, Robby Booth, David C Klonoff. J Diabetes Sci Technol 2020
230
25

Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations.
Awadhesh Kumar Singh, Ritesh Gupta, Amerta Ghosh, Anoop Misra. Diabetes Metab Syndr 2020
207
25

Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19.
Peng Zhang, Lihua Zhu, Jingjing Cai, Fang Lei, Juan-Juan Qin, Jing Xie, Ye-Mao Liu, Yan-Ci Zhao, Xuewei Huang, Lijin Lin,[...]. Circ Res 2020
619
25

Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS.
J K Yang, Y Feng, M Y Yuan, S Y Yuan, H J Fu, B Y Wu, G Z Sun, G R Yang, X L Zhang, L Wang,[...]. Diabet Med 2006
324
25

Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?
Rimesh Pal, Sanjay K Bhadada. Diabetes Res Clin Pract 2020
66
25

Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome.
Loris Roncon, Marco Zuin, Gianluca Rigatelli, Giovanni Zuliani. J Clin Virol 2020
125
25

Glucocorticoid-induced hyperglycemia.
Antonio Perez, Sergio Jansen-Chaparro, Ignasi Saigi, M Rosa Bernal-Lopez, Inka Miñambres, Ricardo Gomez-Huelgas. J Diabetes 2014
88
25

Insulin in the Management of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
Christian D Cerecedo-Lopez, Alejandra Cantu-Aldana, Nirav J Patel, M Ali Aziz-Sultan, Kai U Frerichs, Rose Du. World Neurosurg 2020
5
40


Hospital discharge algorithm based on admission HbA1c for the management of patients with type 2 diabetes.
Guillermo E Umpierrez, David Reyes, Dawn Smiley, Kathie Hermayer, Amna Khan, Darin E Olson, Francisco Pasquel, Sol Jacobs, Christopher Newton, Limin Peng,[...]. Diabetes Care 2014
59
25

More Similarities Than Differences Testing Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Insulin-Naive Type 2 Diabetes: The Randomized Head-to-Head BRIGHT Trial.
Julio Rosenstock, Alice Cheng, Robert Ritzel, Zsolt Bosnyak, Christine Devisme, Anna M G Cali, Jochen Sieber, Peter Stella, Xiangling Wang, Juan P Frías,[...]. Diabetes Care 2018
93
25


Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes.
Guillermo E Umpierrez, Tiffany Hor, Dawn Smiley, Angel Temponi, Denise Umpierrez, Miguel Ceron, Christina Munoz, Christopher Newton, Limin Peng, David Baldwin. J Clin Endocrinol Metab 2009
109
25

Efficacy and safety of insulin degludec U100 and insulin glargine U100 in combination with meal-time bolus insulin in hospitalized patients with type 2 diabetes: an open-label, randomized controlled study.
Jun Suzuki, Tadashi Yamakawa, Mari Oba, Jo Nagakura, Erina Shigematsu, Haruka Tamura, Kenichiro Takahashi, Yoshihisa Okamoto, Rika Sakamoto, Minori Shinoda,[...]. Endocr J 2019
4
50

[Hospital management of hyperglycemia].
Antonio Pérez Pérez, Pedro Conthe Gutiérrez, Manuel Aguilar Diosdado, Vicente Bertomeu Martínez, Pedro Galdos Anuncibay, Gonzalo García de Casasola, Ramón Gomis de Bárbara, José Luis Palma Gamiz, Manuel Puig Domingo, Angel Sánchez Rodríguez. Med Clin (Barc) 2009
39
25

Efficacy and Safety of Flexible Versus Fixed Dosing Intervals of Insulin Glargine 300 U/mL in People with Type 2 Diabetes.
Matthew C Riddle, Geremia B Bolli, Philip D Home, Richard M Bergenstal, Monika Ziemen, Isabel Muehlen-Bartmer, Marek Wardecki, Laetitia Vinet, Nathalie Jeandidier, Hannele Yki-Järvinen. Diabetes Technol Ther 2016
33
25

A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient Management of Medicine and Surgery Patients With Type 2 Diabetes: Glargine U300 Hospital Trial.
Francisco J Pasquel, M Cecilia Lansang, Ameer Khowaja, M Agustina Urrutia, Saumeth Cardona, Bonnie Albury, Rodolfo J Galindo, Maya Fayfman, Georgia Davis, Alexandra Migdal,[...]. Diabetes Care 2020
5
40

Consequences of COVID-19 on people with diabetes.
Virginia Bellido, Antonio Pérez. Endocrinol Diabetes Nutr (Engl Ed) 2020
4
50

Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes.
Guillermo E Umpierrez, Scott D Isaacs, Niloofar Bazargan, Xiangdong You, Leonard M Thaler, Abbas E Kitabchi. J Clin Endocrinol Metab 2002
25

Practical recommendations for the management of diabetes in patients with COVID-19.
Stefan R Bornstein, Francesco Rubino, Kamlesh Khunti, Geltrude Mingrone, David Hopkins, Andreas L Birkenfeld, Bernhard Boehm, Stephanie Amiel, Richard Ig Holt, Jay S Skyler,[...]. Lancet Diabetes Endocrinol 2020
320
25

Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China.
Bo Li, Jing Yang, Faming Zhao, Lili Zhi, Xiqian Wang, Lin Liu, Zhaohui Bi, Yunhe Zhao. Clin Res Cardiol 2020
730
12

COVID-19 and diabetes: Knowledge in progress.
Akhtar Hussain, Bishwajit Bhowmik, Nayla Cristina do Vale Moreira. Diabetes Res Clin Pract 2020
243
12

Endocrine and metabolic link to coronavirus infection.
Stefan R Bornstein, Rinkoo Dalan, David Hopkins, Geltrude Mingrone, Bernhard O Boehm. Nat Rev Endocrinol 2020
143
12

Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort Study.
Julia A Critchley, Iain M Carey, Tess Harris, Stephen DeWilde, Fay J Hosking, Derek G Cook. Diabetes Care 2018
108
12

Potential Effect of Hydroxychloroquine in Diabetes Mellitus: A Systematic Review on Preclinical and Clinical Trial Studies.
Dawit Zewdu Wondafrash, Tsion Zewdu Desalegn, Ebrahim M Yimer, Arega Gashaw Tsige, Betelhem Anteneh Adamu, Kaleab Alemayehu Zewdie. J Diabetes Res 2020
24
12

Prerehabilitation alanine aminotransferase blood levels and one-year mortality rates in older adults following hip fracture.
Rasekh Kashkosh, Irina Gringauz, Jonathan Weissmann, Gad Segal, Michael Swartzon, Abraham Adunsky, Dan Justo. Int J Rehabil Res 2020
2
50

Predictors of poor functional outcomes and mortality in patients with hip fracture: a systematic review.
Bang Yu Xu, Shi Yan, Lian Leng Low, Farhad Fakhrudin Vasanwala, Sher Guan Low. BMC Musculoskelet Disord 2019
27
12

Low alanine aminotransferase levels predict low muscle strength in older patients with diabetes: A nationwide cross-sectional study in Korea.
Seung Min Chung, Jun Sung Moon, Ji Sung Yoon, Kyu Chang Won, Hyoung Woo Lee. Geriatr Gerontol Int 2020
6
16

Glucose variability during delirium in diabetic and non-diabetic intensive care unit patients: A prospective cohort study.
Kris van Keulen, Wilma Knol, Svetlana V Belitser, Irene J Zaal, Paul D van der Linden, Eibert R Heerdink, Toine C G Egberts, Arjen J C Slooter. PLoS One 2018
5
20


The association of alanine transaminase with aging, frailty, and mortality.
David G Le Couteur, Fiona M Blyth, Helen M Creasey, David J Handelsman, Vasi Naganathan, Philip N Sambrook, Markus J Seibel, Louise M Waite, Robert G Cumming. J Gerontol A Biol Sci Med Sci 2010
87
12

Error-prone DNA repair pathways as determinants of immunotherapy activity: an emerging scenario for cancer treatment.
Daniele Caracciolo, Caterina Riillo, Mariamena Arbitrio, Maria Teresa Di Martino, Pierosandro Tagliaferri, Pierfrancesco Tassone. Int J Cancer 2020
3
33

Low ALT blood levels predict long-term all-cause mortality among adults. A historical prospective cohort study.
E Ramaty, E Maor, N Peltz-Sinvani, A Brom, A Grinfeld, S Kivity, S Segev, Y Sidi, T Kessler, B A Sela,[...]. Eur J Intern Med 2014
26
12

Association of Glucose Fluctuations with Sarcopenia in Older Adults with Type 2 Diabetes Mellitus.
Noriko Ogama, Takashi Sakurai, Shuji Kawashima, Takahisa Tanikawa, Haruhiko Tokuda, Shosuke Satake, Hisayuki Miura, Atsuya Shimizu, Manabu Kokubo, Shumpei Niida,[...]. J Clin Med 2019
21
12


Precision Medicine in Interventional Cardiology.
Thijmen W Hokken, Joana M Ribeiro, Peter P De Jaegere, Nicolas M Van Mieghem. Interv Cardiol 2020
1
100


Ciprofloxacin and risk of hypolycemia in non-diabetic patients.
Abiel Berhe, Mulugeta Russom, Fithawit Bahran, Goitom Hagos. J Med Case Rep 2019
3
33

High prevalence of impaired awareness of hypoglycemia and severe hypoglycemia among people with insulin-treated type 2 diabetes: The Dutch Diabetes Pearl Cohort.
Lian A van Meijel, Femmie de Vegt, Evertine J Abbink, Femke Rutters, Miranda T Schram, Melanie M van der Klauw, Bruce H R Wolffenbuttel, Sarah Siegelaar, J Hans DeVries, Eric J G Sijbrands,[...]. BMJ Open Diabetes Res Care 2020
10
12

L3 skeletal muscle index (L3SMI) is a surrogate marker of sarcopenia and frailty in non-small cell lung cancer patients.
D Portal, L Hofstetter, I Eshed, C Dan-Lantsman, T Sella, D Urban, A Onn, J Bar, G Segal. Cancer Manag Res 2019
20
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.